title: Use of a sensitive neutralization assay to measure the prevalence of antibodies to the human immunodeficiency virus.
authors.affiliation: Division of Virology, Food and Drug Administration, Bethesda, Maryland.
authors.forename: L K
authors.initials: LK
authors.lastname: Vujcic
authors.forename: D H
authors.initials: DH
authors.lastname: Shepp
authors.forename: M
authors.initials: M
authors.lastname: Klutch
authors.forename: M A
authors.initials: MA
authors.lastname: Wells
authors.forename: R M
authors.initials: RM
authors.lastname: Hendry
authors.forename: A E
authors.initials: AE
authors.lastname: Wittek
authors.forename: L
authors.initials: L
authors.lastname: Krilov
authors.forename: G V
authors.initials: GV
authors.lastname: Quinnan
mesh_terms: D000386:AIDS-Related Complex / Q000276:immunology; D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology; D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis*; D000918:Antibody Specificity; D002648:Child; D006678:HIV / Q000276:immunology; D015483:HIV Antibodies; D006801:Humans; D009500:Neutralization Tests
chemical_list: D000914:Antibodies, Viral; D015483:HIV Antibodies